Skip to main content
TipRanks
Go Ultimate75% OFF

Protagenic Therapeutics (PTIX) Stock Price & Analysis

98 Followers

PTIX Stock Chart & Stats

$0.42-$0.04(-8.10%)
At close: 4:00 PM EST
$0.5$0.75$1Aug 24Sep 8Sep 21Oct 6Oct 19Nov 2Nov 16
Day’s Range
$0.42 - $0.45
52-Week Range
$0.13 - $2.38
Previous Close
$0.46
Volume
N/A
Average Volume (3M)
1,430
Market Cap
$828.17K
Enterprise Value
$1.69T
Total Cash (Recent Filing)
$76.91K
Total Debt (Recent Filing)
$0
Price to Earnings (P/E)
0.1
Beta
-1.83
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Clinical Trial Progress

Advancing clinical trials for PT00114 indicates progress in drug development, potentially leading to new revenue streams upon successful commercialization.

Innovative Therapeutic Approach

A unique therapeutic mechanism can create a competitive advantage in treating CNS disorders, enhancing market position and long-term growth prospects.

Intellectual Property Strength

Securing patents strengthens the company's intellectual property portfolio, protecting innovations and supporting long-term competitive positioning.

Bears Say

Financial Instability

Persistent financial losses and lack of revenue highlight challenges in achieving financial stability, increasing reliance on external funding.

Negative Cash Flow

Negative cash flow from operations indicates unsustainable financial practices, potentially limiting the company's ability to fund R&D and growth.

Deteriorating Equity

Decreasing equity reflects weakening financial health, which could hinder the company's ability to invest in future growth opportunities.

Protagenic Therapeutics News

PTIX FAQ

What was Protagenic Therapeutics’s price range in the past 12 months?
Protagenic Therapeutics lowest stock price was $0.13 and its highest was $2.38 in the past 12 months.
What is Protagenic Therapeutics’s market cap?
Protagenic Therapeutics’s market cap is $828.17K.
When is Protagenic Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Protagenic Therapeutics’s earnings last quarter?
Protagenic Therapeutics released its earnings results on Apr 01, 2024. The company reported -$5.443 earnings per share for the quarter.
Is Protagenic Therapeutics overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Protagenic Therapeutics pay dividends?
Protagenic Therapeutics does not currently pay dividends.
What is Protagenic Therapeutics’s EPS estimate?
Protagenic Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Protagenic Therapeutics have?
Protagenic Therapeutics has 1,810,208 shares outstanding.
What happened to Protagenic Therapeutics’s price movement after its last earnings report?
Protagenic Therapeutics reported an EPS of -$5.443 in its last earnings report. Following the earnings report the stock price went down -2.874%.
Which hedge fund is a major shareholder of Protagenic Therapeutics?
Currently, no hedge funds are holding shares in PTIX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology